Glenn D Crater

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsPsycholinguistics (incl. speech production and comprehension)Pharmaceutical delivery technologiesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 25, 2026
Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial.

Filip K Knop, George Kunos, Dror Dicker

|Jul 24, 2025
A cannabinoid receptor 1 inverse agonist induces weight loss and reduces airway hyperresponsiveness in a mouse model of obese asthma.

Carolyn R Morris, Ravishankar Chandrasekaran, Isabella M Butzirus

|Apr 01, 2024
Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.

Jill A Ohar, Donald A Mahler, Gabrielle N Davis

|Mar 02, 2022
Lung deposition of inhaled once-daily long-acting muscarinic antagonists via standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients with chronic obstructive pulmonary disease.

Glenn D Crater, Karmon Johnson, Jonathan Ward

|Feb 29, 2020
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.

Sanjay Sethi, James F Donohue, Gary T Ferguson

|Nov 01, 2019
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).

James F Donohue, Edward Kerwin, Sanjay Sethi

Pageof 1

Frequent Collaborators

1 joint publications

Filip K Knop

1 joint publications

George Kunos

1 joint publications

Dror Dicker

1 joint publications

Jean-Sebastien Paquette